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Background: Computed tomography (CT) has been used for non-invasive quantitative assess-
ment of airway dimensions, potentially showing airway remodeling, in asthma. However, most
studies have examined either only one airway or only airways in anatomically unidentified
cross-sections. Using software capable of precisely identifying the generation of airways and
measuring airway dimensions perpendicular to the long axis of airways, we examined, in older
patients with stable asthma, how inter-subject variation in airway dimensions correlated
among the 3rd to 6th generation of airways, and then examined relationships between airway
dimensions of each generation and indices of airflow limitation.
Methods: Subjects aged 55 years old comprised 59 asthmatic patients who underwent CT and
pulmonary function tests on the same day. We measured airway wall area (WA%) and inner
luminal area (Ai) from the 3rd to the 6th generation of eight bronchi in the right lung.
Results: Excellent correlations were identified for both WA% and Ai among the generations
(rZ 0.744e0.930 for WA%) when we took the average of all measured bronchi per generation
as a personal representative value. Significant correlations of airflow limitation indices with
both WA% and Ai/BSA were found at each of the 3rd to 6th generations with similar correlation
coefficients (WA% for FEV1 %predicted, r Z 0.410 to 0.556).
Conclusions: In older patients with stable asthma, airway wall thickening and narrowing
might occur in a parallel manner through 3rd to 6th generation airways. Airway dimensions
at these areas of airways may thus have significant and similar correlations with indices of
airflow limitation.
ª 2010 Elsevier Ltd. All rights reserved.; Ao, outer area of the bronchus; BSA, body surface area; COPD, chronic obstructive pulmonary
Di, inner diameter; ICS, inhaled corticosteroid; IgE, Immunoglobulin E; WA, airway wall area; 3D,
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Bronchial asthma is characterized by reversible airflow
limitation and hyperresponsiveness to constricting stimuli.
Pulmonary function tests, however, have revealed that
airflow limitations in some patients fail to reverse
completely despite optimal treatment.1,2 This phenomenon
has been assumed to result from poorly reversible struc-
tural changes in airway remodeling, including increased
airway smooth muscle mass and sub-epithelial thickening of
the basement membrane.3
Computed tomography (CT) has been used for non-inva-
sive quantitative assessment of airway dimensions, poten-
tially indicating airway remodeling and providing valuable
morphological information about the airways in vivo.4e21
Airway wall thickening and airway narrowing have been
repeatedly reported in patients with asthma compared with
healthy controls.4e6,8,16,17,22,23 However, only a few studies
have attempted to examine relationships between indices of
airflow limitation and airway wall dimensions detected on
CT in stable asthmatic patients. In some reports, analyses
have been limited to airway dimensions of only one airway or
only of the third generation,16,22,23 while other reports have
attempted to analyze more distal airways, but have exam-
ined only airways cut in cross-section on CT, so airway
dimensions were probably compared at anatomically
different generations.7,24,25 Only recently, Montaudon
et al.26 examined the relationship between morphometri-
cally derived airway indices using 3-dimensional (3D)-CT and
indices of airflow limitation. They introduced interesting
parameters, namely slope of the wall area/lumen area and
slope of wall area/total wall area as a function of genera-
tion, revealing that these parameters correlated signifi-
cantly with some indices of airflow limitation. However,
relationships of airway dimensions among bronchial gener-
ations or between airway dimensions at each generation and
airflow limitation indices have not yet been explored.
The present study aimed to apply our 3D software (AZE,
Tokyo, Japan) for a structure-function study in older
patients with stable asthma, by which we could identify the
generation of airways and measure accurate cross-sectional
images of airways until the 6th generation. The specific
aims were to examine how inter-subject variations in
airway dimensions correlated among the 3rd to 6th gener-
ation of airways, and to clarify relationships between
airway dimensions of each generation and indices of airflow
limitation in those patients.
Methods
Subjects
Asthmatic patients who consented to participate in this
study were prospectively recruited from Hokkaido Univer-
sity Hospital and Hokkaido Social Insurance Hospital from
2006 through 2009. Bronchial asthma was diagnosed based
on the American Thoracic Society criteria.27 Entry criteria
were: i) clinically stabledthat is, the patient had not
experienced any asthma attacks or major changes in
medication for >6 weeks before study entry; ii) age 55
years; iii) lifelong non-smokers or smokers with a <10-pack/year lifetime smoking history; and iv) no obvious signs
of emphysema on CT. Duration of disease was defined as
the duration from when the patient first recollected
wheezing to the time of examination.
All study protocols were approved by the Health
Authority Research Ethics Committee of Hokkaido Univer-
sity School of Medicine.
CT data acquisition and analysis
CT was performed using a multidetector-row spiral CT
scanner with 64 detector arrays (Aquilion Multi, TSX-101A/
6A; Toshiba Medical Systems, Gunma, Japan). Data were
acquired with the following parameters: 120 kVp; 300 mA;
64 detector  0.5-mm collimation; slice thickness, 0.5 mm;
0.5 s/rotation; helical pitch, 41. The entire lung was
scanned with the patient in a supine position, holding his or
her breath in deep inspiration. On the study day, the
patients were asked to take their medications as usual.
Data were transferred to a work station and then recon-
structed into 3D images. The detailed process of CT data
acquisition and reconstruction has been described previ-
ously28 and is available in the Online Repository. Identifi-
cation of the generation of bronchi relied on careful
inspection, simultaneously using longitudinal and short-axis
images and searching for any bifurcations in the entire
circumference. We first define a segmental bronchus as the
3rd generation of bronchi, and then proceed toward
peripherally, using the longitudinal image and the short-
axis image simultaneously and searching for any bifurcation
all around circumference.
On the monitor of the work station, image interpretation
was performed using window width of 1000 and a window
level of 700. From the centroid point of the lumen, rays
fanning out over 360were examined to determine airway
wall thickness along the rays using the full-width at half-
maximum principle.29,30 After this process, if the outline of
automatically obtained airway walls was obviously out of
contour, correction was made. Based on manual plotting at
several points, our software used cubic spline interpolation
and built a new circle. Finally, we obtained values for the
inner luminal area (Ai) and the outer area of the bronchus
(Ao). At each bifurcation, we randomly selected one
bronchus in general. In the case that image of one bronchus
is poor or one bronchus is obstructed, however, we then
selected one which would have been more easily identified
until the 6th generation. We measured airway dimensions
of eight bronchi in the right lung; apical (B1), posterior
(B2), and anterior (B3) of the upper lobe; lateral (B4) and
medial (B5) of the middle lobe; and anterior basal (B8),
lateral basal (B9), and posterior basal (B10) of the lower
lobe, at the midpoint between bifurcations, from the 3rd to
6th generation. A representative view of one airway for
analysis is shown in Fig. 1. As shown in Fig. 1c, Wall Area
(WA) was calculated as (AoAi). We then determined wall
area percent (WA%) defined as WA/Ao  100 and Ai after
correcting for body surface area (Ai/BSA) for the parame-
ters of airway dimensions. We took the average from all
bronchi measured for comparison among generations and
for comparison with airflow limitation indices. All
measurements were performed by one of the authors
(K.S.), who was blinded to any other subject information.
Figure 1 a) A curved multiplanar reconstruction (MPR) image of the anterior basal bronchus from the right lower lobe. b) Short-
axis images, obtained from the curved MPR image, are precisely perpendicular to the long axis of the airway. Identification of the
generation of bronchi relied on careful inspection, simultaneously using longitudinal and short-axis images and searching for any
bifurcations in the entire circumference. At each bifurcation, we randomly selected one bronchus. Red lines and circles indicate
the same sites analyzed. c) We measured inner luminal area (Ai), outer area of the bronchus (Ao). Wall Area (WA) was calculated as
(AoAi) and Wall area corrected for the size of the bronchus was calculated as WA/Ao (WA%).
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We conducted pulmonary function tests at 1e3 h after CT
was performed. We measured spirometry, diffusing
capacity for carbon monoxide, and lung volumes assessed
by the helium closed-circuit method (CHESTAC-33; Chest
M.I., Tokyo, Japan). Spirometric measurements included
forced vital capacity (FVC), forced expiratory volume in 1 s
(FEV1), and maximal mid-expiratory flow (MMF). Lung
volume measurements included total lung capacity (TLC),
functional residual capacity (FRC), and residual volume
(RV). Details of procedures and prediction equations used
are described in the Online Repository. Spirometry was
repeated 30 min after inhalation of 200 mg of salbutamol
to evaluate the remaining reversibility on the examination
day. We used pre-bronchodilator values of pulmonary
function parameters for comparison with the data obtained
from CT.
Statistical analysis
SPSS software (SPSS, Tokyo, Japan) was used for all statis-
tical analyses. All the data are expressed as
mean  standard error of the mean for comparison. We
used analysis of variance to analyze differences among
lobes and among generations in mean values of WA% and of
Ai/BSA. Pearson correlation coefficients were used to
examine relationships among the 3rd to 6th generations of
airways, and also relationships between airway dimensions
and pulmonary function parameters. Values of p < 0.05
were considered significant.Results
Characteristics of the 59 subjects who met the entry
criteria are presented in Table 1. The step classification
of asthma was based on the Global Initiative for
Asthma 2005.31
Most subjects were classified as moderate persistent
or severe persistent. The majority of the subjects [55/59;
93%] were taking inhaled corticosteroids and 26 patients
[44%] were taking long-acting b agonist inhalers and
28 patients [47%] were taking leukotriene receptor antag-
onists. Results of pulmonary function tests are summarized
in Table 3. Although all subjects were clinically stable, FEV1
%predicted varied from 49.7% to 112.5% (mean,
87.1  2.1%). A similar wide variation was observed for
other pulmonary function parameters, and FEV1/FVC was
<70% in 41 patients (69%). The reversibility of airflow
limitation was 6.5  0.8%. Nine patients increased their
FEV1 by more than 200 ml and 12% from the baseline after
inhaling a bronchodilator.
Online Table E1 shows mean values for two airway
parameters (Ai/BSA, WA%) at all 32 measurement sites, from
the3rd to 6th generation of eight bronchi in the right lung.We
failed to obtain data at all 32 measurement sites in some
subjects, as clear images of airways could not always be
obtained. The number of subjects for whom measurements
were available at each site is shown in Online Table E1; we
missed data from a considerable number of subjects, partic-
ularly at the5thand6thgenerationsofB4,B5,andB9bronchi.
Averages were taken from all bronchi measured per
generation for later analyses. Excellent correlations in
Table 1 Characteristics of subjects.
n (male/female) 59 (22/37)
Age, years 67.4  0.9 (55e86)
Height m 1.56  0.01 (1.37e1.70)
Weight kg 59.1  1.1 (43e77)
BMI kg/m2 24.4  0.4 (19.1e32.4)
BSA m2 1.58  0.02 (1.31e1.87)
STEP (intermittent/mild persistent/moderate persistent/severe persistent) 0/5/16/38
Duration of asthma, years 17.6  2.1 (1e62)
Blood eosinophils per ml 302.5  29.7 (12e1031)
Total IgE IU/ml 243.3  64.1 (0e2902.8)
Data are shown as means  standard error. BMI: body mass index BSA: body surface area IgE: Immunoglobulin E.
The step classification of asthma was based on the Global Initiative for Asthma 2005.
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mean Ai/BSA among generations (Table 2, Table E1).
We then examined relationships between mean WA% at
each generation and pulmonary function parameters.
Significant correlations were seen between airway dimen-
sions at all generations and indices of airflow limitation,
including FEV1 %predicted (Fig. 2), FEV1/FVC, and MMF %
predicted (Table 4).
Of note, correlation coefficients were similar from the
3rd to 6th generations. Since mean values for WA% and
Ai/BSA correlated well at all bronchial generations (3rd,
r Z 0.867; 4th, r Z 0.857; 5th, r Z 0.881; 6th,
r Z 0.870; p < 0.01), similar relationships between
structure and function were found also for Ai/BSA (Table 4).
In other words, the more pulmonary function deteriorated,
the thicker the airway wall and the narrower the airway
caliber became at any generation.
Duration of asthma also correlated significantly with
Ai/BSA and WA% at any generation, suggesting that patients
with longer duration had thicker airway walls and narrower
airway caliber (Table 4).
Finally, we performed a separate analysis by sex, as
airway dimensions and airway remodeling may differ
between men and women (Online Tables E2, E3). We
generally found similar results in both groups and significant
correlations of WA% with pulmonary function parameters,
including FEV1 %predicted, FEV1/FVC, MMF %predicted, and
FEV1 at the 3rd to 6th generations.Discussion
This study simultaneously measured pulmonary function
and airway dimensions from the 3rd to 6th generation of
eight bronchi in the right lung of 59 older patients withTable 2 Relationships of mean WA% in all bronchi among the 3
Correlation coefficients 3rd
3rd e
4th e
5th e
6th e
**p < 0.01.clinically stable asthma. First, we found excellent corre-
lations in inter-subject variation of both WA% and Ai/BSA
among the 3rd to 6th generations when we took average
data from all bronchi measured per generation. Second,
significant correlations were noted between indices of
airflow limitation and airway dimensions at any level from
the 3rd to 6th generation with similar correlation coeffi-
cients. Interestingly, this contrasts with COPD, where
airway dimensions from the 5th to 6th generation demon-
strated better correlations with indices of airflow limitation
than airway dimensions from the 3rd to 4th airways in our
previous study.32
We chose either lifelong non-smokers or past smokers
with a lifetime smoking history of <10 packs/year whose
age was 55 years old. Furthermore, we excluded individ-
uals with any evidence of apparent emphysema on lung CT.
Consequently, subjects who showed airflow limitation in
this study were likely to have poorly reversible airway
remodeling, largely caused by long-standing bronchial
asthma, which is concordant with the results of previous
studies.33e35Another distinct reason for choosing only
older subjects for the present study was that we were
concerned about the risks of radiation exposure in younger
subjects.36
The present investigation took the average of all bronchi
measured per generation as a representative value. Aysola
et al.23 recently used an automated, quantitative 3D
approach to assess airway remodeling in bronchial asthma
and measured airway dimensions at all segmental bronchi
(comparable to the 3rd generation) from both lungs. They
recognized the heterogeneity of airway dimensions among
bronchi and thus took the average for comparison with
pulmonary function. The present study demonstrated that
the inter-subject variations in airway dimensions were very
consistent among the generations from the 3rd to the 6thrd to 6th generations.
4th 5th 6th
0.863** 0.834** 0.744**
e 0.930** 0.844**
e e 0.864**
e e e
Table 3 Pulmonary function tests before and after salbutamol.
Pulmonary function tests Baselinea Add-onb
VC, l 3.03  0.09 (1.71e4.44) 3.11  0.09 (1.81e4.73)
VC, %predicted 106.7  1.50 (76.7e132.8) 109.1  1.62 (81.2e137.4)
FEV1, l 1.90  0.06 (0.78e3.01) 2.03  0.06 (0.86e3.24)
FEV1, %predicted 87.1  2.1 (49.7e112.5) 93.7  2.06 (54.9e123.8)
FEV1/FVC, % 64.3  1.3 (41.4e83.3) 66.4  1.3 (44.1e84.7)
MMF, %predicted 60.2  4.2 (11.0e162.2) 65.3  4.5 (15.6e162.2)
DLCO, %predicted 109.8  2.5 (71.4e161.6)
DLCO/VA, %predicted 114.2  2.6 (75.8e189.7)
TLC, %predicted 110.6  1.5 (74.0e131.1)
FRC, %predicted 92.1  2.2 (57.9e127.8)
RV, %predicted 105.8  2.4 (68.1e165.5)
RV/TLC, % 37.1  0.7 (26.1e51.3)
VC, vital capacity; FEV1, forced expiratory volume in 1 s; MMF, maximum mid-expiratory flow rate; DLCO, carbon monoxide diffusing
capacity; VA, alveolar volume; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume.
Data are shown as means  standard error.
a Baseline: with usual medication.
b Add-on: after inhaling 200 mg of salbutamol.
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support the concept that airway diseasedthat is, wall
thickening and/or airway narrowingdare likely to progress
in a similar fashion from the 3rd to 6th bronchial genera-
tions at least in older asthmatics who are clinically stable.
In other words, airway alteration at the 3rd generation
could offer a good surrogate marker for changes in more
distal airways of those asthmatic patients. This was echoed
in COPD by Nakano et al.,37 who demonstrated that mean
WA% measured by CT for airways with a luminal perimeter
>0.75 cm approximately predicted the mean dimensions of
small airways with an internal diameter of 1.27 mm.37 The
equivalent diameter (Di) of an airway with a luminal
perimeter of 0.75 cm is 2.39 mm, which is almost equiva-
lent diameter of airways from the 5th to 6th generation in
our subjects.
Although numerous CT studies have been performed in
bronchial asthma, only a few have attempted to examine
relationships between indices of airflow limitation and
airway wall dimensions detected on CT in well-controlled
asthmatic patients. Some investigators have examined only
the segmental levels of bronchus.16,22,23 Others have
attempted to analyze more distal airways,7,24,38 but had to
choose only airways cut in cross-section on CT slices and to
compare airway dimensions that were probably at different
generations. While some found significant correlations of
wall thickness with airflow limitation,24,38 others failed to
find such correlations.7 We found significant relationships
between indices of airflow limitation and airway dimen-
sions at the 3rd to 6th airway generations in older patients
with clinically stable asthma and, in addition, confirmed
that correlation coefficients were very similar among
generations.
In COPD, we and others have previously reported that
correlation coefficients of airway dimensions with airflow
limitation indices were better in distal airways than in
proximal airways of the 3rd to the 6th generations.32,39,40
In this study, however, we did not find such characteris-
tics in terms of structureefunction relationship. This may
be explained by differences in the site of airwayremodeling between diseases. Another explanation may lie
in the effect of elastic recoil pressure surrounding the
airway on inner luminal area. In COPD, not only airway
disease but also emphysema is likely to contribute airway
narrowing, thus causing Ai to be more closely correlated
with function compared with WA%, whereas both Ai and WA
% have similar relationships with function in bronchial
asthma. The third explanation is that the degree of airflow
limitation observed in this study populationwas not as severe
as inCOPD, so the involvement of airway remodeling from5th
to the 6th generation might not have been notable.
Of particular note, we found significant relationships of
airflow limitation indices not only with WA%, but also with
Ai/BSA. In contrast with airway wall thickening, which has
been repeatedly reported in patients with bronchial
asthma, controversy remains regarding airway luminal
area. Although some studies have shown reduced airway
luminal area in patients with bronchial asthma compared
with healthy controls,8,17 other have found no such differ-
ences.16,22 Our data suggest that airway wall thickening
leads to airway narrowing, when the patients display
airflow limitation.
Several limitations in this study require consideration.
First, only older subjects with stable asthma were enrolled
and most were classified as moderate persistent or severe
persistent. Thus, the results in this study might not be
applicable to younger patients nor patients who would be
classified as intermittent and/or mild persistent. Second, as
pulmonary function of the subjects overall was relatively
preserved, it might be premature to compare the findings of
this study with those of the past studies which had dealt with
COPD. Comparison between the asthma and COPD would be
highly interesting if the level of airflow limitation was
comparable in the two groups. Third, sex-related differ-
ences have recently been reported not only in emphy-
sema,41 but also in airway disease in COPD.42 Subjects in this
study comprised 22 men and 37 women, so that the numbers
may have been inadequate for comparison between sexes.
Finally, we must also note technological limitations of our 3D
airway analysis. As not all of the 5th and 6th generation of
Figure 2 Relationships between FEV1, %predicted and mean WA% of all bronchi measured. Significant correlations were seen
between WA% and FEV1 %predicted at all airway generations. Data from men and women are separately shown in Online E2, E3,
respectively. Wall area corrected for the size of the bronchus was calculated as WA/Ao (WA%).
1814 K. Shimizu et al.airways could be identified, there might have been selection
bias of sampled airways. However, the advantage would be
that we could compare the data per generation among the
subjects, which could not have been performed in any of theTable 4 Correlation coefficients of the mean airway dimension
of asthma.
Pulmonary function tests 3rd
a) Ai/BSA
VC, %predicted 0.021
FEV1, l 0.419**
FEV1, %predicted 0.299*
FEV1/FVC, % 0.324*
MMF, %predicted 0.347**
TLC, %predicted 0.193
FRC, %predicted 0.023
RV, %predicted 0.246
RV/TLC, % 0.344**
Duration of asthma 0.290*
b) WA%
VC, %predicted 0.006
FEV1, l 0.419**
FEV1, %predicted 0.410**
FEV1/FVC, % 0.413**
MMF, %predicted 0.409**
TLC, %predicted 0.084
FRC, %predicted 0.018
RV, %predicted 0.150
RV/TLC, % 0.228
Duration of asthma 0.348**
VC, vital capacity; FEV1, forced expiratory volume in 1 s; MMF,
FRC, functional residual capacity; RV, residual volume.
*p < 0.05; **p < 0.01.past studies. Excellent correlations in airway dimensions
among the generations of airways we found in this study may
indicate superiority of our 3D analysis over other previously
reported analyses, despite such bias. Another technicals of eight bronchi with pulmonary function tests and duration
4th 5th 6th
0.075 0.045 0.098
0.438** 0.354** 0.326*
0.445** 0.508** 0.482**
0.461** 0.519** 0.446**
0.483** 0.544** 0.491**
0.221 0.227 0.174
0.150 0.231 0.217
0.316* 0.340** 0.348**
0.350** 0.296* 0.288*
0.355** 0.352** 0.353**
0.009 0.007 0.017
0.472** 0.463** 0.462**
0.514** 0.556** 0.430**
0.529** 0.575** 0.424**
0.497** 0.541** 0.398**
0.205 0.223 0.242
0.184 0.219 0.158
0.292* 0.323* 0.375**
0.308* 0.284* 0.337**
0.410** 0.372** 0.346**
maximum mid-expiratory flow rate; TLC, total lung capacity;
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method for determination of airway wall because this algo-
rithm is reported to underestimate airway luminal area and to
overestimate airway wall thickness particularly in airways of
small diameters.43 We, however, compared the data among
the subjects, using the same generation of airways (i.e. the
similar size of airways), which would minimize the potential
systemic errors. Finally, even with progress in CT technology
and the present advanced algorithms, we cannot yetmeasure
the airway dimensions of what we call “small airways,” which
are defined as those with diameters <2 mm.
In conclusion, in clinically stable and older asthmatics,
excellent correlations existed in inter-subject variation of
airway dimensions measured by 3D-CT, among the 3rd to
6th generations, supporting the concept that airway wall
thickening and airway narrowing occurs similarly at these
areas of airways. Second, airway dimensions correlated
significantly with indices of airflow limitation at any level
from the 3rd to 6th generation of airways to a similar extent
in those asthmatic population.
Acknowledgements
We wish to thank Dr Nobuyuki Hizawa, Dr Daisuke Takaha-
shi, Dr Yukiko Maeda, Dr Akira Isada, Dr Ayumu Takahashi,
Dr Takeshi Hattori, Dr Kenichi Shimizu of our department
and Dr Yasushi Akiyama, Dr Toshiyuki Harada of Hokkaido
Social Insurance Hospital for recruiting the patients.
We also extend our appreciation to the Division of Radi-
ology, the Division of Pulmonary Function, and the
Department of Laboratory Medicine at Hokkaido University
Hospital for technical assistance.Conflict of interest
This study was supported by a scientific research grant from
the Ministry of Education, Science, Culture and Sports
of Japan (to MN [19390221]).
The authors declare that they have no competing
interests to disclose.Appendix. Supplementary data
The supplementary data associated with this article
can be found in the on-line version at doi:10.1016/
j.rmed.2010.06.013.References
1. Bai TR, Cooper J, Koelmeyer T, et al. The effect of age and
duration of disease on airway structure in fatal asthma. Am J
Respir Crit Care Med 2000;162:663e9.
2. Pascual RM, Peters SP. Airway remodeling contributes to the
progressive loss of lung function in asthma. J Allergy Clin
Immunol 2005;116:477e86.
3. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of
persistent asthma. J Allergy Clin Immunol 2000;105:1041e53.4. Awadh N, Muller NL, Park CS, et al. Airway wall thickness in
patients with near fatal asthma with or without fixed airflow
obstruction. Thorax 1998;53:248e53.
5. Ketai L, Coutsias C, Williamson S, et al. Thin-section CT
evidence of bronchial thickening in children with stable asthma
bronchoconstriction or airway remodeling? Acad Radiol 2001;8:
257e64.
6. Lee YM, Park JS, Hwang JH, et al. High-resolution CT findings in
patients with near-fatal asthma: comparison of patients with
mild-to-severe asthma and normal control subjects and
changes in airway abnormalities following steroid treatment.
Chest 2004;126:1840e8.
7. Little SA, Sproule MW, Cowan MD, et al. High resolution
computed tomographic assessment of airway wall thickness in
chronic asthma: reproducibility and relationship with lung
function and severity. Thorax 2002;57:247e53.
8. Okazawa M, Muller N, McNamara AE, et al. Human airway
narrowing measured using high resolution computed tomog-
raphy. Am J Respir Crit Care Med 1996;163:994e1001.
9. King GG, Carroll JD, Muller NL, et al. Heterogeneity of nar-
rowing in normal and asthmatic airways measured by HRCT.
Eur Respir J 2004;24:211e8.
10. Laurent F, Latrabe V, Raherison C, et al. Functional signifi-
cance of air trapping detected in moderate asthma. Eur Radiol
2000;10:1404e10.
11. Goldin JG, Tashkin DP, Kleerjp EC, et al. Comparative effects
of hydrofluoroalkane and chlorofluorocarbon beclomethasone
dipropionate inhalation on small airways: assessment with
functional helical thin-section computed tomography.
J Allergy Clin Immunol 1999;104:S258e67.
12. Tunon-de-Lara JM, Laurent F, Giraud V, et al. Air trapping in
mild and moderate asthma: effect of inhaled corticosteroids.
J Allergy Clin Immunol 2007;119:583e90.
13. Hansell DM. Small airways diseases: detection and insights with
computed tomography. Eur Respir J 2001;17:1294e313.
14. Ueda T, Niimi A, Matsumoto H, et al. Role of small airways in
asthma: investigation using high-resolution computed tomog-
raphy. J Allergy Clin Immunol 2006;118:1019e25.
15. Mitsunobu F, Shida K, Hosaki Y, et al. Complexity of terminal
airspace geometry assessed by computed tomography in
asthma. Am J Respir Crit Care Med 2003;167:411e7.
16. Gono H, Fujimoto K, Kawakami S, et al. Evaluation of airway
wall thickness and air trapping by HRCT in asymptomatic
asthma. Eur Respir J 2003;22:965e71.
17. Beigelman-Aubry C, Capderou A, Grenier PA, et al. Mild
intermittent asthma: CT assessment of bronchial cross-
sectional area and lung attenuation at controlled lung volume.
Radiology 2002;223:181e7.
18. Mayer D, Bartz D, Fischer J, et al. Hybrid segmentation and
virtual bronchoscopy based on CT images. Radiology 2004;11:
551e65.
19. Montaudon M, Berger P, de Dietrich G, et al. Assessment of
airways with three-dimensional quantitative thin-section CT.
Radiology 2007;242:563e72.
20. Brillet PY, Fetita CI, Beigelman-Aubry C, et al. Quantification
of bronchial dimensions at MDCT using dedicated software. Eur
Radiol 2007;17:1483e9.
21. Montaudon M, Desbarats P, Berger P, et al. Assessment of
bronchial wall thickness and lumen diameter in human adults
using multi-detector computed tomography: comparison with
theoretical models. J Anat 2007;211:579e88.
22. Niimi A, Matsumoto H, Amitani R, et al. Airway wall thickness
in asthma assessed by computed tomography. Am J Respir Crit
Care Med 2000;162:1518e23.
23. Aysola RS, Hoffman EA, Glarada D, et al. Airway remodeling
measured by multidetector computed tomography is increased
in severe asthma and correlates with pathology. Chest 2008;
134:1183e91.
1816 K. Shimizu et al.24. Kasahara K, Shiba K, Ozawa T, et al. Correlation between the
bronchial subepithelial layer and whole airway wall thickness
in patients with asthma. Thorax 2002;57:242e6.
25. de Blic J, Tillie-Leblond I, Emond S, et al. High-resolution
computed tomography scan and airway remodelling in chil-
dren with severe asthma. J Allergy Clin Immunol 2005;116:
750e4.
26. Montaudon M, Lederlin M, Reich S, et al. Bronchial measure-
ments inpatients with asthma: comparison of quantitative
thin-section CT findings with those in healthy subjects and
correlation with pathologic findings. Radiology 2009;253:
844e53.
27. American Thoracic Society. Standards for the diagnosis and
care of patients with chronic obstructive pulmonary disease
(COPD) and asthma. Am Rev Respir Dis 1987;136:225e44.
28. Nishimura M. Application of three-dimensional airway algo-
rithms in a clinical study. Proc Am Thorac Soc 2008;5:910e4.
29. de Jong PA, Muller NL, Pare PD, et al. Computed tomographic
imaging of the airways: relationship to structure and function.
Eur Respir J 2005;26:140e52.
30. Nakano Y, Whittall KP, Kalloger SE, et al. Development and
validation of human airway analysis algorithm using multi-
detector row CT. Invest Radiol 1999;34:303e9.
31. Global strategy for asthma management and prevention:
NHLBI/WHO Workshop Report National Institutes of Health.
Publication Updated 2005.
32. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airway limitation
and airway dimensions in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2006;173:1309e15.
33. Brinke A, Zwinderman AH, Sterk PJ, et al. Factors associated
with persistent airflow limitation in severe asthma.
Am J Respir Crit Care Med 2001;164:744e8.34. Bumbacea D, Campbell D, Nguyen L, et al. Parameters asso-
ciated with persistent airflow obstruction in chronic severe
asthma. Eur Respir J 2004;24:122e8.
35. Moore WC, Bleecker ER, Curran-Everett DC, et al. Character-
ization of the severe asthma phenotype by the National Heart,
Lung and Blood Institute’s Severe Asthma Research Program.
J Allergy Clin Immunol 2007;119:405e13.
36. Brenner DJ, Hall EJ, Phil D. Computed tomography - an
increasing source of radiation exposure. N Engl J Med 2007;
357:2277e84.
37. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small
airway dimensions using computed tomography. Am J Respir
Crit Care Med 2005;171:142e6.
38. Capez F, Kunter E, Cermik H, et al. The effect of inhaled
budesonide and formoterol on bronchial remodeling and HRCT
features in young asthmatics. Lung 2007;185:89e96.
39. Matsuoka S, Kurihara Y, Yagihashi K, et al. Airway dimensions
at inspiratory and expiratory multisection CT in chronic
obstructive pulmonary disease: correlation with airflow limi-
tation. Radiology 2008;248(3):1042e9.
40. Coxson HO, Quiney B, Sinn DD, et al. Airway wall thickness
assessed using computed tomography and optical coherence
tomography. Am J Respir Crit Care Med 2008;177(11):1201e6.
41. Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in
severe pulmonary emphysema. Am J Respir Crit Care Med
2007;176:243e52.
42. Kim WJ, Silverman EK, Hoffman E, et al. CT metrics of airway
disease and emphysema in severe COPD. Chest 2009;36(2):
396e404.
43. NakanoY,Whittall KP,KallogerSE,CoxsonHO,ParePD,EnglishJC.
Development and validation of human airway analysis algorithm
using multidetector row CT. Proc SPIE 2002;4683:460e9.
